Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany-论文-万方医学网

首页> > Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

导出原文传递

翻译打印收藏纠错

第一作者： Marcel,Reiser

作者： Marcel,Reiser ^[1] ; Klaus M.,Josten ^[2] ; Hermann,Dietzfelbinger ^[3] ; Anouchka,Seesaghur ^[4] ; Markus,Schill ^[5] ; Jane,Hippenmeyer ^[6] ; Manfred,Welslau ^[7]

作者单位： Hematology and Internal Oncology, Praxis Internistische Onkologie und H?matologie (PIOH), Cologne ^[1] Hematology and Internal Oncology, Praxis H?matologie/Onkologie, Wiesbaden, Germany ^[2] Hematology and Internal Oncology, H?matologisch-Onkologische Schwerpunktpraxis, Herrsching, Germany ^[3] Center for Observational Research, Amgen Ltd., London, United Kingdom ^[4] Medical Affairs, Amgen GmbH, Munich, Germany ^[5] Clinical Research, Amgen, Rotkreuz, Switzerland ^[6] Hematology and Internal Oncology, Onkologie Aschaffenburg, Aschaffenburg, Germany ^[7]

关键词 Thrombopoietin-receptor agonist Platelet disorders Chronic/persistent/newly diagnosed immune thrombocytopenia

发布时间 2022-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

相似文献

同项目论文

相关期刊

检索历史 清除

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

相似文献

同项目论文

相关期刊

检索历史清除